Rise in Infertility Cases to Boost Global Human Reproductive Technologies Market to US$27.1 bn by 2019

2026-07-09 01:22:23 Health and Fitness

824

According to a recent market study published by Transparency Market Research (TMR), the global human reproductive technologies market is exhibiting a 2.20% CAGR between 2013 and 2019. The market is expected to be valued at US$27.1 bn by 2019, according to a research report released by Transparency Market Research. The report, titled ?Human Reproductive Technologies Market ? Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 ? 2019?, enumerates the various features of the global human reproductive technologies market and highlights all the factors that influence it, giving a statistical and descriptive analysis in order to draw a conclusion for the market?s forecast.
Browse Full Press Release:http://www.transparencymarketresearch.com/pressrelease/human-reproductive-technologies-market.htm
According to the report, the global human reproductive technologies market is driven by the growing rate of people suffering from infertility. More patients are looking for fertility solutions due to difficulties in conceiving, caused mostly by negative lifestyle changes such as those inducing obesity, and consumption of toxic substances such as alcohol or tobacco (smoked or chewed). The growing rate of infertility is also attributed to an increasing number of individuals opting out of pregnancy or using methods that delay pregnancy. This includes the rising use of contraceptives and other contraception initiatives undertaken by governments or NGOs. Other common factors that cause infertility are stress, pollution, and the lack of access to safe contraceptive methods.The global human reproductive technologies market deals with both aspects of reproduction: birth control and fertilization.
The report explains the global human reproductive technologies market through segmentations based on the criteria of infertility drugs, infertility procedures, contraceptive technologies, and geography.In 2012, the overall value of the global contraceptive market was US$16 bn. This segment is expected to display a CAGR of 5.5% from 2013 to 2019. Within this market, oral contraceptives experienced the highest growth rate in 2012, a fact attributed to increasing awareness towards the concept and the easy availability of oral contraceptives as an over-the-counter drug.
Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876
The global human reproductive technologies market is also significantly boosted by the male contraceptive sub-segment due to the ease of availability of male contraceptives, lack of side effects, and the added benefit of avoiding sexually transmitted diseases.In terms of infertility treatments and procedures, the global human reproductive technologies market was led by intrauterine insemination, due to the low cost of the procedure and its simplicity.
Geographically, the report states North America to be the largest consumer region in the global human reproductive technologies market in 2012, followed closely by Europe. The report also states that North America is expected to lead the global human reproductive technologies market till 2019. On the other hand, the fastest growth rate is attributed to Asia Pacific, owing to the high population density in this region, growing awareness about contraceptives, and increasing disposable income.Key players operating in the global human reproductive technologies market are Teva Pharmaceutical Industries, Ltd., Bayer Healthcare AG, Boston Scientific Corporation, Ferring International Center S.A., Church & Dwight, Co. Inc., and Merck KGaA.
Browse the full Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) ? Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 ? 2019 report at http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html
Key segments of the Global Human Reproductive Technologies Market
Human Reproductive Technologies Market by Infertility Drugs
? Gonal-f (recombinant follitropin alfa)
? Follistim AQ (follitropin beta)
? AndroGel (testosterone)
? Testim (testosterone)
? Viagra (sildenafil citrate)
? Cialis (tadalafil)
? Levitra/Staxyn (vardenafil)
Human Reproductive Technologies Market, by Infertility Procedures
? In Vitro Fertilization (IVF)
? Intracytoplasmic Sperm Injection (ICSI)
? Zygote Intrafallopian Transfer (ZIFT)
? Gamete Intrafallopian Transfer (GIFT)
? Intrauterine Insemination (IUI)
Human Reproductive Technologies Market, by Contraceptive Technologies
? Drugs
? Oral Contraceptive Pills
? Contraceptive Injectables
? Topical Contraceptives
Devices
? Male Contraceptive Devices (Male Condoms)
? Female Contraceptive Devices
Major geographies analyzed under this research report are:
? Europe
? North America
? Asia-Pacific
? Rest of the World
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR?s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.